Executive-Engineering

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to its customers across geographies. Our business is organized into two segments - Specialty Pharmaceuticals and Generics & APIs. Jubilant Generics (JGL), a wholly-owned subsidiary of Jubilant Pharma, has Research & Development units in Noida and Mysore, India. JGL operates two manufacturing facilities in Mysore, Karnataka, and Roorkee, Uttarakhand, engaged in APIs and Dosage manufacturing, respectively. The Mysore manufacturing site, spread over 69 acres, is a USFDA approved facility producing APIs for global sales, with a focus on Lifestyle driven Therapeutic Areas like CVS and CNS. The Roorkee facility is state of the art, approved by multiple regulatory bodies, and operates on a B2B model for EU, Canada, and emerging markets. Backward-integrated manufacturing units are supported by around 500 research and development professionals based at Noida and Mysore. R&D activities include the development of new products in API and various dosage forms like Oral Solid, Sterile Injectable, Semi-Solids, Creams, and Liquids. In-house BA/BE studies are conducted at our 80-bed facility with global regulatory accreditations. JGL's Regulatory Affairs & IPR team ensures a unique portfolio of patents and product filings in regulatory and non-regulatory markets. The revenue of Jubilant Pharma has been on the rise, reaching INR 53,240 Million in the Financial Year 2018-19 compared to INR 39,950 Million in the Financial Year 2017-18. For more information about our organization, please visit www.jubilantpharma.com.,